SHANGHAI and SANTA BARBARA, Calif., Dec. 17, 2025 /PRNewswire/ -- Rona Therapeutics, a global leader in next-generation RNAi medicines, today announced the submission of RN5681 to the Australian Human ...
Proprotein convertase subtilisin/kexin type-9 (PCSK9), highly expressed in adult hepatocytes, increases low-density lipoprotein cholesterol (LDL-C) levels by promoting the degradation of the LDL ...
PCSK9 inhibitors are a type of medication that lowers cholesterol. Doctors may prescribe them to people alongside statins and other cholesterol-lowering drugs. Doctors commonly prescribe statins to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results